|Articles|October 28, 2022
E. coli Plasmid DNA Production in Small Bioreactor
Author(s)Eppendorf
In the biopharmaceutical industry, upstream processing for plasmid DNA production is usually optimized at small scale. We demonstrate the feasibility of using the DASbox® Mini Bioreactor System for process development.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How Mitigation and Maintenance Protect Against Future Risk
2
FAQ: Milestones You May Have Missed in the 2025 Biopharma Pipeline
3
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
4
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
5
